Skip to main content
Erschienen in: International Urology and Nephrology 3/2014

01.03.2014 | Urology - Original Paper

Risk factors for septic shock in acute obstructive pyelonephritis requiring emergency drainage of the upper urinary tract

verfasst von: Jun Kamei, Hiroaki Nishimatsu, Tohru Nakagawa, Motofumi Suzuki, Tetsuya Fujimura, Hiroshi Fukuhara, Yasuhiko Igawa, Haruki Kume, Yukio Homma

Erschienen in: International Urology and Nephrology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the risk factors for septic shock in patients with acute obstructive pyelonephritis requiring emergency drainage of the upper urinary tract.

Methods

We retrospectively reviewed the records of 48 patients who underwent emergency drainage of the upper urinary tract for sepsis associated with acute obstructive pyelonephritis at our institute. Univariate and multivariate analyses were performed to identify the risk factors.

Results

Among 54 events of sepsis, we identified 20 events of septic shock requiring vasopressor therapy. Cases with shock were more likely than those without shock to have ureteral stone (70 vs 38 %, p = 0.024) and positive blood culture results (81 vs 28 %, p = 0.006). They received drainage significantly earlier than those without shock (1.0 vs 3.5 days, p < 0.001). Univariate analysis demonstrated that acute obstructive pyelonephritis by ureteral stone, rapid progression (the occurrence of symptoms to drainage ≤1 day), positive blood culture, leukocytopenia (<4,000/mm3), thrombocytopenia (<120,000/mm3), and prothrombin time international normalized ratio ≥1.20 were correlated with septic shock. Multivariate logistic regression analysis identified thrombocytopenia (p = 0.005) and positive blood culture (p = 0.040) as independent risk factors for septic shock.

Conclusions

Thrombocytopenia and positive blood culture were independent risk factors for septic shock in acute obstructive pyelonephritis requiring emergency drainage. Thrombocytopenia would be practically useful as a predictor of septic shock.
Literatur
1.
Zurück zum Zitat Danuser H, Ackermann DK, Studer UE (1993) Urological emergencies. Schweiz Med Wochenschr 123:749–755PubMed Danuser H, Ackermann DK, Studer UE (1993) Urological emergencies. Schweiz Med Wochenschr 123:749–755PubMed
2.
Zurück zum Zitat Dellinger RP, Carlet JM, Masur H et al (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRef Dellinger RP, Carlet JM, Masur H et al (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRef
3.
Zurück zum Zitat Dellinger RP, Levy MM, Carlet JM et al (2008) International surviving sepsis campaign guidelines committee. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327PubMedCrossRef Dellinger RP, Levy MM, Carlet JM et al (2008) International surviving sepsis campaign guidelines committee. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327PubMedCrossRef
4.
Zurück zum Zitat Yamamoto Y, Fujita K, Nakazawa S et al (2012) Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi. BMC Urol 12:4PubMedCentralPubMedCrossRef Yamamoto Y, Fujita K, Nakazawa S et al (2012) Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi. BMC Urol 12:4PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef
6.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMedCrossRef Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMedCrossRef
7.
Zurück zum Zitat Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124PubMedCrossRef Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124PubMedCrossRef
8.
Zurück zum Zitat Annane D, Sébille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMedCrossRef Annane D, Sébille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMedCrossRef
9.
Zurück zum Zitat Ogura H, Gando S, Iba T et al (2007) SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia. Shock 28:411–417PubMedCrossRef Ogura H, Gando S, Iba T et al (2007) SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia. Shock 28:411–417PubMedCrossRef
10.
Zurück zum Zitat Iba T, Gando S, Murata A et al (2007) Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers. J Trauma 63:1093–1098PubMedCrossRef Iba T, Gando S, Murata A et al (2007) Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers. J Trauma 63:1093–1098PubMedCrossRef
11.
Zurück zum Zitat Amaral A, Opal SM, Vincent JL (2004) Coagulation in sepsis. Intensive Care Med 30:1032–1040PubMedCrossRef Amaral A, Opal SM, Vincent JL (2004) Coagulation in sepsis. Intensive Care Med 30:1032–1040PubMedCrossRef
12.
14.
15.
Zurück zum Zitat Hsu CY, Fang HC, Chou KJ et al (2006) The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 332:175–180PubMedCrossRef Hsu CY, Fang HC, Chou KJ et al (2006) The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 332:175–180PubMedCrossRef
16.
Zurück zum Zitat Martínez JA, Pozo L, Almela M et al (2007) Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. Clin Microbiol Infect 13:709–716PubMedCrossRef Martínez JA, Pozo L, Almela M et al (2007) Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. Clin Microbiol Infect 13:709–716PubMedCrossRef
17.
Zurück zum Zitat van Nieuwkoop C, Bonten TN, van’t Wout JW et al (2010) Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 14:R206PubMedCentralPubMedCrossRef van Nieuwkoop C, Bonten TN, van’t Wout JW et al (2010) Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 14:R206PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedCrossRef Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedCrossRef
19.
Zurück zum Zitat Jones AE, Trzeciak S, Kline JA (2009) The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 37:1649–1654PubMedCentralPubMedCrossRef Jones AE, Trzeciak S, Kline JA (2009) The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 37:1649–1654PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Lin JN, Tsai YS, Lai CH et al (2009) Risk factors for mortality of bacteremic patients in the emergency department. Acad Emerg Med 16:749–755PubMedCrossRef Lin JN, Tsai YS, Lai CH et al (2009) Risk factors for mortality of bacteremic patients in the emergency department. Acad Emerg Med 16:749–755PubMedCrossRef
21.
Zurück zum Zitat Yoshimura K, Utsunomiya N, Ichioka K, Ueda N, Matsui Y, Terai A (2005) Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol 173:458–462PubMedCrossRef Yoshimura K, Utsunomiya N, Ichioka K, Ueda N, Matsui Y, Terai A (2005) Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol 173:458–462PubMedCrossRef
22.
Zurück zum Zitat Lee JH, Lee YM, Cho JH (2012) Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J Infect Chemother 18:130–133PubMedCrossRef Lee JH, Lee YM, Cho JH (2012) Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J Infect Chemother 18:130–133PubMedCrossRef
Metadaten
Titel
Risk factors for septic shock in acute obstructive pyelonephritis requiring emergency drainage of the upper urinary tract
verfasst von
Jun Kamei
Hiroaki Nishimatsu
Tohru Nakagawa
Motofumi Suzuki
Tetsuya Fujimura
Hiroshi Fukuhara
Yasuhiko Igawa
Haruki Kume
Yukio Homma
Publikationsdatum
01.03.2014
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2014
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0545-5

Weitere Artikel der Ausgabe 3/2014

International Urology and Nephrology 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.